C Nuevo-Tapioles, F Santacatterina… - Nature …, 2020 - nature.com
Mitochondrial metabolism has emerged as a promising target against the mechanisms of tumor growth. Herein, we have screened an FDA-approved library to identify drugs that …
I Romero-Carramiñana, PB Esparza-Moltó… - Communications …, 2023 - nature.com
The coexistence of two pools of ATP synthase in mitochondria has been largely neglected despite in vitro indications for the existence of reversible active/inactive state transitions in …
JM Cuezva, S Domínguez-Zorita - Cancers, 2024 - mdpi.com
Simple Summary The ATPase Inhibitory Factor 1 (IF1) plays a prominent role as an inhibitor of mitochondrial ATP synthase. Herein we review the role of IF1 in promoting the Warburg …
PB Esparza-Moltó, I Romero-Carramiñana… - PLoS …, 2021 - journals.plos.org
The mitochondrial ATP synthase emerges as key hub of cellular functions controlling the production of ATP, cellular signaling, and fate. It is regulated by the ATPase inhibitory factor …
The ATPase inhibitory factor 1 (IF1) is an intrinsically disordered protein that regulates the activity of the mitochondrial ATP synthase. Phosphorylation of S39 in IF1 prevents it from …
L García-Ledo, C Nuevo-Tapioles… - Frontiers in …, 2017 - frontiersin.org
Partial suppression of mitochondrial oxidative phosphorylation and the concurrent activation of aerobic glycolysis is a hallmark of proliferating cancer cells. Overexpression of the …
Results HCT116 and Jurkat cancer cells have a fraction of inactive ATP synthase. HCT116 cells were used for the generation of IF1-knock-out (IF1-KO) cells by CRISPR-Cas9 …